A prospective study of the usefulness of liquid biopsy as biomarker during diagnosis and treatment for the cervical cancer

A prospective study of the usefulness of liquid biopsy as biomarker during diagnosis and treatment for the cervical cancer - A prospective study of the usefulness of liquid biopsy as biomarker for the cervical cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000027121

Enrollment

Registered

2017-05-08

Start date

2017-05-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical cancer

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: The patients with cervical cancer who are planned to treat according our protocol.

Exclusion criteria

Exclusion criteria: The patients are followed our protocol.

Design outcomes

Primary

Measure	Time frame
Correlation between gene mutation by liquid biopsy and progression free survival.	—

Secondary

Measure	Time frame
PFS by liquid biopsy OS by liquid biopsy	—

Countries

Japan

Contacts

Public ContactNaoyuki Iwahashi

Wakayama Medical University Obstetrics and gynecology

naoyuki@wakayama-med.ac.jp0734410631

Outcome results